ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Clinical trials for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield: cholesterol drug may prevent Chemo-Induced cardiac damage
Prevention Not yet recruitingThis study tests whether rosuvastatin, a cholesterol-lowering drug, can prevent heart damage in women with breast cancer receiving anthracycline chemotherapy. 400 participants will take either rosuvastatin or a placebo daily for 12 months. The main goal is to see if the drug help…
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated May 16, 2026 23:49 UTC
-
VR program aims to teach heart health to breast cancer survivors
Knowledge-focused Not yet recruitingThis study tests a virtual reality (VR) program called SurviVRSE that teaches breast cancer survivors about heart health. About 30 women currently receiving certain cancer treatments will try the VR program. Researchers will check if the program is easy to use, acceptable, and if…
Matched conditions: ANTHRACYCLINE RELATED CARDIOTOXICITY IN BREAST CANCER
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC